Iguana Healthcare Management, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Iguana Healthcare Management, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q1 2018$3,059,000
+31.9%
60,000
+20.0%
2.01%
+33.2%
Q4 2017$2,319,000
-56.5%
50,000
-50.0%
1.51%
+2.8%
Q3 2017$5,326,000
+14.3%
100,000
+33.3%
1.47%
-44.2%
Q2 2017$4,658,000
-8.4%
75,0000.0%2.63%
+4.7%
Q1 2017$5,084,000
-54.8%
75,000
-53.1%
2.52%
-62.6%
Q4 2016$11,250,000
-60.4%
160,000
-60.0%
6.72%
+32.9%
Q3 2016$28,376,000
+314.4%
400,000
+185.7%
5.06%
+81.6%
Q2 2016$6,847,000
-9.9%
140,000
+16.7%
2.78%
+0.0%
Q1 2016$7,597,000
-41.1%
120,000
+4.3%
2.78%
-34.4%
Q4 2015$12,901,000
+21.8%
115,000
+4.5%
4.24%
+1.9%
Q3 2015$10,594,000
-48.3%
110,000
-45.0%
4.17%
-35.5%
Q2 2015$20,478,000
+88.5%
200,000
+14.3%
6.46%
+41.3%
Q1 2015$10,866,000
+395.3%
175,000
+250.0%
4.57%
+331.2%
Q4 2014$2,194,000
-32.6%
50,000
-13.0%
1.06%
-39.0%
Q3 2014$3,255,000
+73.5%
57,500
+37.6%
1.74%
+98.7%
Q2 2014$1,876,000
-30.2%
41,800
-24.0%
0.88%
-29.6%
Q1 2014$2,689,00055,0001.24%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2016
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders